Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip to Present at Stephens Fall Investment Conference
DENVER , Oct. 31, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Stephen Deitsch , Senior Vice President, Chief Financial Officer and Treasurer and
Toggle Summary BioScrip to Host Third Quarter Results Call
DENVER , Oct. 16, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will release its third quarter 2017 financial results on Thursday,
Toggle Summary BioScrip Announces Availability of ALS Home Infusion Therapy
DENVER , Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, is pleased to announce that it can now dispense and administer Radicava® (edaravone), the first treatment
Toggle Summary BioScrip Reports Second Quarter 2017 Financial Results
– Net revenue of $218.1 million , including core product mix of 73.1% compared to 60.3% in the prior year – Net loss from continuing operations of $28.7 million , compared to $8.3 million in the prior year, reflecting increased non-cash expenses and interest – Adjusted EBITDA of $10.0 million ,
Toggle Summary BioScrip Applauds US House Passage of HR3178, the Medicare Part B Improvement Act of 2017
Legislation Accelerates Medicare Payment of Home Infusion Therapy Services to 2019 DENVER , July 26, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the US
Toggle Summary BioScrip To Host Second Quarter Results Call
DENVER , July 17, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will release its second quarter 2017 financial results on Tuesday, August
Toggle Summary BioScrip Announces New Senior Note Facilities
Agreement Will Immediately Improve Capital Structure, Provide Operational Flexibility, and Result in Excess of $50 million in Liquidity DENVER , June 29, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and
Toggle Summary BioScrip Provides Update on UnitedHealthcare Contract
DENVER , May 30, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has reached an agreement to continue to provide certain core product lines
Toggle Summary BioScrip to Present at the Jefferies 2017 Global Healthcare Conference
DENVER , May 24, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports First Quarter 2017 Financial Results
Q1 Consolidated Revenue of $217.8 Million, loss from continuing operations net of income taxes of $19.0 million and Adjusted EBITDA of $5.2 Million DENVER , May 04, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced its first quarter 2017 financial